Mumtaz Balkhi joins TWiP to discuss phase 1 and 1b trials of the schistosomiasis vaccine SchistoShield which demonstrate that it induces functional immune memory responses in US and African populations.
Hosts: Vincent Racaniello, Daniel Griffin, and Christina Naula
Guest: Mumtaz Y. Balkhi
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Links for this episode
- Join the MicrobeTV Discord server
- SchistoShield Phase 1 and 1b results (npj Vaccines)
- TWiP study – information and survey
Become a patron of TWiP
Send your questions and comments to twip@microbe.tv
Music by Ronald Jenkees